Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.1.1.17ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BA.1.1.17SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.1.1.17SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-18441.9South Korea
BA.1.1.17EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.1.1.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.17NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.1.17NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BS.1.1ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
BS.1.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BS.1.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BS.1.1SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BS.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BS.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BS.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BS.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CM.1ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
CM.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
CM.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
CM.1SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
CM.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
B.1.451SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.451SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.451EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.451EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.451NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.451NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.8ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.1.8ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.1.8SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.1.8SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.1.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.313ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.313ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.313SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.313SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.313EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.313EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.313NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.313NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.402ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.402ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.402SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.402SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.402EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.402EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.402NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.402NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used